文献速递冠心病血脂与心血管预防

光学相干断层扫描检测富含脂质斑块的临床意义:4年随访研究

Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

该研究纳入20个国家6个中心1474例接受PCI且行靶血管OCT成像的患者,随访中位2年、最长4年。结果显示33.6%患者非罪犯区域存在富含脂质斑块,其48个月非罪犯病变相关MACE累积率高于无富含脂质斑块者(7.2% vs 2.6%,p=0.033)。

要点

  • 靶血管非罪犯区域OCT检出富含脂质斑块者占33.6%。
  • 富含脂质斑块者48个月NC-MACE累积率7.2%,无富含脂质斑块者2.6%。
  • 急性冠脉综合征、停用他汀≥1年及非罪犯区域富含脂质斑块与NC-MACE独立相关。

核心结论

  • OCT检测到靶血管非罪犯区域富含脂质斑块可预测未来非罪犯病变相关MACE风险增加。
  • 该风险主要由因复发性缺血而进行的血运重建所驱动。
  • 脂质长度更长、脂质弧更宽及狭窄程度更高的富含脂质斑块患者未来心脏事件风险更高。

研究设计与样本

  • 研究纳入来自6个国家20个中心的1474例接受PCI且行靶血管OCT成像的患者。
  • 主要不良心脏事件(MACE)定义为心源性死亡、急性心肌梗死和缺血驱动的血运重建组成的复合终点。
  • 随访最长4年,中位随访2年。

主要发现

  • 33.6%的患者在靶血管非罪犯区域检出富含脂质斑块。
  • 富含脂质斑块患者48个月非罪犯病变相关MACE累积率为7.2%,无富含脂质斑块者为2.6%(p=0.033)。
  • 初次就诊时急性冠脉综合征与NC-MACE风险升高独立相关(风险比2.538;95%CI:1.246至5.173;p=0.010)。
  • 停用他汀≥1年与NC-MACE风险升高独立相关(风险比4.517;95%CI:1.923至10.610;p=0.001)。
  • 非罪犯区域存在富含脂质斑块与NC-MACE风险升高独立相关(风险比2.061;95%CI:1.050至4.044;p=0.036)。

关键数值与推荐

  • 发生NC-MACE患者的富含脂质斑块较无MACE患者脂质长度更长(p<0.001)。
  • 发生NC-MACE患者的富含脂质斑块较无MACE患者最大脂质弧更宽(p=0.023)。
  • 发生NC-MACE患者的富含脂质斑块较无MACE患者最小管腔面积更小(p=0.003)。

临床怎么用

  • 原文未提供临床实践推荐。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lipid-rich plaque (LRP) is thought to be a precursor to cardiac events. However, its clinical significance in coronary arteries has never been systematically investigated. OBJECTIVES: This study investigated the prevalence and clinical significance of LRP in the nonculprit region of the target vessel in patients undergoing percutaneous coronary intervention (PCI). METHODS: The study included 1,474 patients from 20 sites across 6 countries undergoing PCI, who had optical coherence tomography (OCT) imaging of the target vessel. Major adverse cardiac events (MACE) were defined as a composite of cardiac death, acute myocardial infarction, and ischemia-driven revascularization. Patients were followed for up to 4 years (median of 2 years). RESULTS: Lipid-rich plaque was detected in nonculprit regions of the target vessel in 33.6% of patients. The cumulative rate of nonculprit lesion-related MACE (NC-MACE) over 48 months in patients with LRP was higher than in those without LRP (7.2% vs. 2.6%, respectively; p = 0.033). Acute coronary syndrome at index presentation (risk ratio: 2.538; 95% confidence interval [CI]: 1.246 to 5.173; p = 0.010), interruption of statin use ≥1 year (risk ratio: 4.517; 95% CI: 1.923 to 10.610; p = 0.001), and LRP in nonculprit regions (risk ratio: 2.061; 95% CI: 1.050 to 4.044; p = 0.036) were independently associated with increased NC-MACE. Optical coherence tomography findings revealed that LRP in patients with NC-MACE had longer lipid lengths (p < 0.001), wider maximal lipid arcs (p = 0.023), and smaller minimal lumen areas (p = 0.003) than LRPs in patients without MACE. CONCLUSIONS: Presence of LRP in the nonculprit regions of the target vessel by OCT predicts increased risk for future NC-MACE, which is primarily driven by revascularization for recurrent ischemia. Lipid-rich plaque with longer lipid length, wider lipid arc, and higher degree of stenosis identified patients at higher risk of future cardiac events. (The Massachusetts General Hospital Optical Coherence Tomography Registry; NCT01110538).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Xing L, Higuma T, Wang Z, et al. Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study. J Am Coll Cardiol. 2017. PMID: 28521888. doi:10.1016/j.jacc.2017.03.556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。